Drugs associated with reversible cerebral vasoconstriction syndrome: A pharmacovigilance study in vigiBase<sup>®</sup>
The present study confirms the role of vasoconstrictors in the onset of RCVS, particularly when used in combination and found potential signals, which may help clinicians envisage an iatrogenic etiology of RCVS.
Authors
- G. Veyrac
- Julien Mahé (ORCID: https://orcid.org/0000-0001-9721-8150)
- Claire Lafay‐Chebassier (ORCID: https://orcid.org/0000-0001-8970-5514)
- Marie Christine Pérault‐Pochat
- Sylvie Favrelière
- Jean Philippe Neau
Institutions
- Centre Hospitalier Universitaire de Nantes (FR)
- Centre Hospitalier Universitaire de Poitiers (FR)
Publication Details
- Journal
- Cephalalgia
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1177/03331024241267316
- Citations
- 9
- Primary Topic
- Neurological Complications and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 3.47